|
Session 164
Poster Abstracts
HIV/TB Co-infection
Wednesday, 1-4 pm
Room: Hall B |
| 998 |
TB Risk and Smoking in HIV-infected Adults: A Prospective Cohort
Neil Martinson*1, J Golub1, R Chaisson1, M Moshabela2, N Tshabangu2, G de Bruyn2, S Nayagar2, G Gray2, J McIntyre2, and P Pronyk3
1Johns Hopkins Univ Ctr for TB Res, Baltimore, MD, US; 2Univ of the Witwatersrand, Johannesburg, South Africa; and 3Univ of the Witwatersrand Sch of Publ Hlth, Johannesburg, South Africa |
| 999 |
Decreased Mortality Associated with Latent TB Treatment among HIV-infected Persons in Tanzania
Conrad Kabali*1, L Mtei2, F von Reyn3, K Pallangyo2, R Waddell3, and R Horsburgh1
1Boston Univ Sch of Publ Hlth, MA, US; 2Muhimbili Univ Coll of Hlth Sci, Dar es Salaam, Tanzania; and 3Dartmouth Med Sch, Hanover, NH, US |
| 1000 |
Characteristics and Clinical Outcome of Patients with HIV-associated TB in Europe and Argentina
Daria Podlekareva*1, A Mocroft2, A Panteleev3, J Toibaro4, A Rakhmanova5, V Riekstina6, H Furrer7, O Suetnov8, F Post9, O Kirk1, and the HIV/TB Study Group
1Copenhagen HIV Prgm, Univ of Copenhagen, Denmark; 2Royal Free and Univ Coll Med Sch, London, UK; 3St Petersburg City TB Hosp #2, Russia; 4Hosp JM Ramos Mejia, Buenos Aires, Argentina; 5Botkin Hosp of Infectious Diseases, St Petersburg, Russia; 6State Agency of TB and Lung Diseases, Riga, Latvia; 7Univ Hosp Bern, Switzerland; 8Regional Ctr for AIDS Prophylaxis, Gomel, Belarus; and 9King`s Coll London, UK |
| 1001 |
TB after HAART Initiation in the US and Canada
Timothy Sterling and North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the IeDEA
Vanderbilt Univ, Nashville, TN, US |
| 1002 |
Effect of TB on HIV Viral Load Response in Patients Accessing ART at Themba Lethu Clinic, South Africa
Sharlaa Faesen*1, B Malope-Kgokong1, D Westreich2, P MacPhail1, and I Sanne1
1Univ of the Witwatersrand, Johannesburg, South Africa and 2Univ of North Carolina at Chapel Hill, US |
| 1003 |
FoxP3-expressing Cells Are Poorly Represented in Lymph Nodes from HIV/M. tuberculosis Co-infected Patients
Lidia Gazzola*1, M Nebuloni2, F Zanini3, M Saresella4, G Marchetti1, M Clerici5, A d'ARMINIO MONFORTE1, and A Gori6
1San Paolo Hosp, Univ of Milan, Italy; 2Luigi Sacco Hosp, Univ of Milan, Italy; 3Luigi Sacco Hosp, Univ of Milan, Italy; 4Don Carlo Gnocchi Fndn, Milan, Italy; 5Univ of Milan, Italy; and 6San Gerardo Hosp, Univ of Milan-Bicocca, Italy |
| 1004 |
Maturation of Dendritic Cells by M. tuberculosis Dramatically Inhibits MHC-II Antigen Presentation of HIV-1
David Canaday* and D McDonald
Case Western Reserve Univ Sch of Med, Cleveland, OH, US |
| 1005 |
A Factorial Study of the Effect of HIV, TB, and Pharmacogenetics on the Pharmacokinetics and Pharmacodynamics of Anti-TB Drugs
Geraint Davies*1,2, N Cheirakul3, N Saguenwong4, A Chaiprasert3, C Chuchuttaworn5, B Eompokalap4, S Likanonsakul4, N White2, D Back1, and S Khoo1
1Univ of Liverpool, UK; 2Faculty of Tropical Med, Mahidol Univ, Bangkok, Thailand; 3Siriraj Hosp, Bangkok, Thailand; 4Bamrasnaradura Infectious Diseases Inst, Nonthaburi, Thailand; and 5Central Chest Hosp, Nonthaburi, Thailand |
|
